MX2019011701A - Composiciones de canabinoide y usos. - Google Patents

Composiciones de canabinoide y usos.

Info

Publication number
MX2019011701A
MX2019011701A MX2019011701A MX2019011701A MX2019011701A MX 2019011701 A MX2019011701 A MX 2019011701A MX 2019011701 A MX2019011701 A MX 2019011701A MX 2019011701 A MX2019011701 A MX 2019011701A MX 2019011701 A MX2019011701 A MX 2019011701A
Authority
MX
Mexico
Prior art keywords
glycol
composition
monohydric
polyhydric alcohol
cannabinoid compositions
Prior art date
Application number
MX2019011701A
Other languages
English (en)
Inventor
Hearn Alex
Gupta Ritika
Bowdrey Moira
Original Assignee
Kind Consumer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB1402678.5A external-priority patent/GB2524469A/en
Application filed by Kind Consumer Ltd filed Critical Kind Consumer Ltd
Publication of MX2019011701A publication Critical patent/MX2019011701A/es

Links

Abstract

Una composición inhalable para el uso como un medicamento en el tratamiento de un sujeto en donde la composición comprende uno o más canabinoides o un derivado farmacéuticamente aceptable o sal de los mismos, un propelente, un alcohol monohídrico o polihídrico; y un glicol y/o éter de glicol, caracterizado en que la relación de alcohol monohídrico o polihídrico a glicol o éter de glicol en peso es de 6:1 a 1:1, en donde la composición se administra en la forma de un aerosol que tiene una fracción de partícula fina de 60% o más.
MX2019011701A 2014-02-14 2016-08-12 Composiciones de canabinoide y usos. MX2019011701A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1402678.5A GB2524469A (en) 2014-02-14 2014-02-14 A cannabinoid inhaler and composition therefor
US201461941724P 2014-02-19 2014-02-19
GB1420943.1A GB2525269A (en) 2014-02-14 2014-11-25 Cannabinoid compositions and uses

Publications (1)

Publication Number Publication Date
MX2019011701A true MX2019011701A (es) 2020-01-09

Family

ID=72039316

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019011701A MX2019011701A (es) 2014-02-14 2016-08-12 Composiciones de canabinoide y usos.

Country Status (1)

Country Link
MX (1) MX2019011701A (es)

Similar Documents

Publication Publication Date Title
NZ723838A (en) Cannabinoid compositions and uses
PH12015500686A1 (en) Nicotine composition
PH12018502747A1 (en) Boronic acid derivatives and therapeutic uses thereof
MX2019005379A (es) Derivado de pirazolo-heteroarilo, metodo de preparacion y uso medico del mismo.
MX2021006035A (es) Formulaciones cannabinoides estables.
MX2023007033A (es) Extractos de cannabis y metodos de preparacion y uso de la misma.
TN2016000007A1 (en) Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalation
BR112015000229A2 (pt) formulações aquosas estáveis de etanercept
MX368903B (es) Compuestos terapéuticos y sus usos en el tratamiento de enfermedades proliferativas.
SG10201806854XA (en) Compositions comprising 15-ohepa and methods of using the same
WO2015033302A3 (en) Fulvestrant compositions
MY175781A (en) Composition comprising at least two dry powders obtained by spray drying to increase the stability of the formulation
MY193740A (en) "substituted 2,4 diamino-quinoline as new anticancer agents"
MX2016001422A (es) Composicion farmaceutica de fingolimod.
MD4563C1 (ro) Produs de comicronizare cu conţinut de acetat de ulipristal
MY191712A (en) Composition comprising at least one dry powder obtained by spray drying to increase the stability of the formulation
MX2015011588A (es) Tratamiento de combinacion.
IN2013MU01177A (es)
MX2019011701A (es) Composiciones de canabinoide y usos.
GEP20196957B (en) Crystalline forms of s-acetyl glutathione, their reparations and uses in pharmaceutical and nutraceutical formulations
NZ702684A (en) Hexadepsipeptide analogues as anticancer compounds
MX2017002627A (es) Derivados de polieteres macrociclicos de n-aril-2-amino-4-aril-pir imidina como inhibidores de ftl3 y jak.
WO2014106826A3 (en) Anthracycline analogue and uses thereof
MX2017013103A (es) Metodos para el tratamiento de trastornos cardiovasculares.
MX2017002747A (es) Derivados de polieteres macrociclicos de n-aril-triciclopirimidin- 2-amino como inhibidores de ftl3 y jak.